Doctor reviewing scans and medical records with a patient
    Regenerative Therapy

    Which Conditions Has MUSE Cells Therapy Been Studied For?

    November 6, 202610 min read

    Why Patients Ask Which Conditions MUSE Cells Therapy Treats

    If you have searched MUSE cells therapy, you have probably seen long lists of conditions. Few of them have published human results. This guide sorts conditions by the strength of evidence, so you can see where your own diagnosis fits.

    New to the topic? Start with what MUSE cells are and how they differ from MSCs.

    MUSE Cells Therapy Conditions by Evidence Level

    ConditionEvidence stageRead more
    Subacute ischaemic strokeSmall placebo-controlled human trialMUSE cells after stroke
    Acute heart attackFirst-in-human study in 3 patientsMUSE cells and heart attack
    Dystrophic epidermolysis bullosaSmall open-label human studyMUSE cells and EB
    Liver fibrosis and cirrhosisAnimal studies onlyMUSE cells and cirrhosis
    Tinnitus and hearingNo published human MUSE result foundMUSE cells and tinnitus

    What Human MUSE Cells Therapy Studies Show

    Niizuma and colleagues reported a randomised placebo-controlled trial of CL2020 in subacute ischaemic stroke. Noda and colleagues reported a first-in-human study in three heart attack patients. Fujita and colleagues reported a phase 1/2 open-label study in adults with dystrophic epidermolysis bullosa.

    These studies were designed mainly to check safety and early signals. They are too small to establish effectiveness. See MUSE cell safety evidence.

    MUSE Cell Therapy Approach Across Conditions

    • How it works: MUSE cells are proposed to sense injury signals, travel to damaged tissue and support repair.
    • Who may be suitable: no routine candidate group exists. Suitability depends on the condition, its stage and available evidence.
    • What a session involves: the human studies used intravenous infusion. See what a MUSE stem cell treatment visit involves.
    • Limits: early-phase or animal evidence only. No condition has a proven MUSE cure.

    Depending on the condition, other regenerative options such as MSC therapy may be discussed as options. Visit our MUSE cell therapy service page.

    How to Check MUSE Cells Therapy Claims for Your Condition

    • Is there a published human study for this exact condition?
    • How many people were studied, and was there a comparison group?
    • Was the same cell product used as the one offered?
    • What established care should continue alongside?

    Comparing technologies? Read MUSE cells vs iPS cells.

    For kidney concerns, read MUSE cell therapy and chronic kidney disease.

    Next Steps After Reviewing MUSE Cells Therapy Evidence

    If you are considering travel, our guide to planning MUSE cell therapy in Thailand lists the questions to ask a provider. Interested in longevity rather than one diagnosis? Read MUSE cell therapy for healthy aging.

    Bottom line: MUSE cells therapy has early human data in stroke, heart attack and epidermolysis bullosa, and animal data elsewhere. It remains investigational for every condition.

    Medical References

    Talk to a Doctor Before You Decide

    Tell us your diagnosis and share your records. Our team can explain where MUSE cells therapy evidence stands for your condition and which established options come first.

    Schedule a Consultation

    Frequently Asked Questions

    Published human studies cited here cover subacute ischaemic stroke, acute heart attack and dystrophic epidermolysis bullosa. All were small and early-phase.

    Liver fibrosis and cirrhosis, among others, have been studied in animal models. Human benefit for these is unknown.

    We did not find a regulatory approval for a MUSE cell product in the sources we reviewed. Treat it as investigational.

    Without published human evidence for your condition, benefit is unknown. A doctor can explain established options and any relevant registered studies.

    MUSE cells are a small stress-tolerant subpopulation found within MSC and other tissues. MSC therapy uses the broader cell population and has its own separate evidence.

    Related Articles